QUESTION NO:  313 DÁIL QUESTION addressed to the Minister for Health (Leo Varadkar) by Deputy Anthony Lawlor for WRITTEN ANSWER on 25/11/2014

*  To ask the Minister for Health the reason Our Lady’s Children’s Hospital Crumlin withdrew physiotherapy services for children with referrals from rheumatoid paediatricians without any alternative service being available to them in the Kildare West Wicklow area; in view of the extensive delays experienced by children in the area, if he will confirm when physiotherapists in the Kildare west Wicklow area will be in a position to provide the services required by children with referrals from rheumatoid paediatricians; and if he will make a statement on the matter. – Anthony Lawlor T.D.


PQ Reply from HSE 27th January, 2015

The Children’s Hospital Group has been working with all stakeholders in the provision of this service to ensure that services are provided in the most appropriate setting for children and that care pathways are clear and unambiguous.  This service is appropriate to the community setting not to an acute tertiary paediatric  hospital.  Meeting have been held with Our Lady’s Children’s Hospital, Crumlin, Primary Care Services in Kildare West Wicklow, the Disability Services Network and Naas Hospital to clarify the position.  Current provision of both physiotherapy and occupational therapy for all service users with a non-inflammatory condition is available through the Primary Care Service, for children with inflammatory conditions, but no other complications, occupational therapy is available but physiotherapy services needs to be and is being enhanced by the provision of additional resources within Primary Care, (with upskilling and support provided by the specialists in Our Lady’s Children’s Hospital, Crumlin as appropriate) to ensure that these children are seen in a community setting.  The development of this service is being geared to meet the needs of those currently waiting as well as future needs. The third group of children with an inflammatory condition and other co-morbidities will receive their therapy from the Disability Services Network. The above pathway is now agreed with all stakeholders and is being implemented immediately. ENDS